​

Viatris (VTRS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VTRS Stock Forecast

Viatris (VTRS) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $15.00, with a high of $15.00 and a low of $15.00. This represents a 45.77% increase from the last price of $10.29.

$10 $11 $12 $13 $14 $15 High: $15 Avg: $15 Low: $15 Last Closed Price: $10.29

VTRS Stock Rating

Viatris stock's rating consensus is Hold, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (9.09%), 8 Hold (72.73%), 2 Sell (18.18%), and 0 Strong Sell (0.00%).

Hold
Total 11 0 2 8 1 Strong Sell Sell Hold Buy Strong Buy

VTRS Price Target Upside V Benchmarks

TypeNameUpside
StockViatris45.77%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks18.82%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$15.00$15.00$15.00
Last Closing Price$10.29$10.29$10.29
Upside/Downside45.77%45.77%45.77%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25125-19
Sep, 25125-19
Aug, 25125-19
Jul, 25126-110
Jun, 25125-19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2025Truist Financial$15.00$9.9351.06%45.77%
Jul 19, 2024Glen SantangeloJefferies$15.00$11.7727.44%45.77%
Mar 28, 2024David AmsellemPiper Sandler$13.00$11.839.89%26.34%
Jun 26, 2023David AmsellemPiper Sandler$10.00$9.841.63%-2.82%
Feb 01, 2023Barclays$15.00$12.1623.36%45.77%
Nov 09, 2022Ashwani VermaUBS$12.00$10.8310.80%16.62%
Jun 13, 2022Ashwani VermaUBS$9.00$10.77-16.43%-12.54%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 07, 2025JefferiesBuyBuyhold
Mar 05, 2025Piper SandlerNeutralNeutralhold
Mar 28, 2024Piper SandlerNeutralNeutralhold
Jan 12, 2024Cowen & Co.Market Performdowngrade
Dec 27, 2023Morgan StanleyEqual-WeightEqual-Weighthold
Sep 27, 2023Wells FargoEqual-WeightEqual-Weighthold
Jun 26, 2023BMO CapitalPerformMarket Performdowngrade
Feb 17, 2023BMO CapitalMarket PerformPerformdowngrade
Feb 17, 2023BMO CapitalMarket Performdowngrade
Feb 01, 2023BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.11$-1.05$1.71$0.05$-0.53---
Avg Forecast$4.56$3.72$3.39$2.96$2.68$2.63$2.69$2.58
High Forecast$4.68$3.81$3.42$3.00$2.71$2.75$3.70$2.63
Low Forecast$4.49$3.66$3.36$2.90$2.65$2.51$1.57$2.49
Surprise %-124.34%-128.23%-49.56%-98.31%-119.78%---

Revenue Forecast

$12B $13B $14B $16B $17B $19B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$11.95B$17.89B$16.26B$15.43B$14.74B---
Avg Forecast$12.29B$17.89B$16.37B$15.47B$14.81B$14.29B$14.35B$16.56B
High Forecast$12.52B$18.23B$16.45B$15.53B$14.86B$14.52B$14.38B$16.80B
Low Forecast$12.14B$17.67B$16.24B$15.42B$14.70B$13.95B$14.32B$16.13B
Surprise %-2.78%-0.01%-0.67%-0.30%-0.49%---

Net Income Forecast

$-2B $0 $2B $3B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-669.90M$-1.27B$2.08B$54.70M$-634.20M---
Avg Forecast$5.51B$-1.13B$66.99M$54.70M$3.24B$3.17B$3.18B$3.09B
High Forecast$5.64B$-795.14M$309.54M$252.76M$3.27B$3.32B$4.46B$3.17B
Low Forecast$5.42B$-1.47B$-175.56M$-143.36M$3.20B$3.02B$1.90B$3.01B
Surprise %-112.17%12.29%3002.87%--119.59%---

VTRS Forecast FAQ

Is Viatris stock a buy?

Viatris stock has a consensus rating of Hold, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Viatris is a neutral investment for most analysts.

What is Viatris's price target?

Viatris's price target, set by 11 Wall Street analysts, averages $15 over the next 12 months. The price target range spans from $15 at the low end to $15 at the high end, suggesting a potential 45.77% change from the previous closing price of $10.29.

How does Viatris stock forecast compare to its benchmarks?

Viatris's stock forecast shows a 45.77% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the specialty & generic drug manufacturers stocks industry (18.82%).

What is the breakdown of analyst ratings for Viatris over the past three months?

  • October 2025: 11.11% Strong Buy, 22.22% Buy, 55.56% Hold, 0% Sell, 11.11% Strong Sell.
  • September 2025: 11.11% Strong Buy, 22.22% Buy, 55.56% Hold, 0% Sell, 11.11% Strong Sell.
  • August 2025: 11.11% Strong Buy, 22.22% Buy, 55.56% Hold, 0% Sell, 11.11% Strong Sell.

What is Viatris’s EPS forecast?

Viatris's average annual EPS forecast for its fiscal year ending in December 2025 is $2.63, marking a -596.23% decrease from the reported $-0.53 in 2024. Estimates for the following years are $2.69 in 2026, and $2.58 in 2027.

What is Viatris’s revenue forecast?

Viatris's average annual revenue forecast for its fiscal year ending in December 2025 is $14.29B, reflecting a -3.05% decrease from the reported $14.74B in 2024. The forecast for 2026 is $14.35B, and $16.56B for 2027.

What is Viatris’s net income forecast?

Viatris's net income forecast for the fiscal year ending in December 2025 stands at $3.17B, representing a -600.11% decrease from the reported $-634M in 2024. Projections indicate $3.18B in 2026, and $3.09B in 2027.